A Population Health analysis app for Specialty Drugs.
Populated from claims from Pharmspective’s data partner, eMaxHealth, CareView™ displays cost-of-care analysis for a distribution of claims for five cost segments of patients for Autoimmune and Oncology drugs. By segmenting patients by specialty drug and cost-of-care for the top 10%, next 15%, middle 50%, lower 15%, and lowest 10% of total cost, CareView™ provides a detailed look at where opportunities may exist for interventions and changes in care management to more efficiently manage care.
- Rxs or Courses of Therapy for each patient cost-of-care measurement period
- # of Providers who are part of the patient’s care team
- Number of Admissions and Costs for Emergency Department and Inpatient site-of-care
- Specialty Drug Costs and Total Pharmacy Costs
- Mean and Median Total Resource Costs